CV Sciences launches PlusCBD Pain Relief Topicals
CV Sciences has launched a new product line called PlusCBD Pain Relief Topicals, which includes four products formulated with hemp-derived CBD, and active drug ingredients such as menthol and camphor to pinpoint sources of pain and discomfort.
Photo © iStockphoto.com/Wavebreakmedia
CV Sciences (San Diego, CA) has launched a new product line called PlusCBD Pain Relief Topicals, which includes four products formulated with hemp-derived CBD, and active drug ingredients such as menthol and camphor to pinpoint sources of pain and discomfort. The products include: PlusCBD Pain Relief Sports Recovery Stick, PlusCBD Pain Relief Penetrating Cream, PlusCBD Pain Relief Muscle Cream, and PlusCBD Pain Relief Arthritis Cream.
“Finding new ways to improve our customers’ quality of life is at the heart of what we do at CV,” said Joseph Dowling, CEO of CV Sciences, in a press release. “Our latest range of topical products offers a non-invasive, holistic alternative to OTC pain relievers, using quality hemp and CBD to alleviate common sources of pain. PlusCBD’s Pain Relief line is just another example of how science-backed innovations in CBD can transform the way we approach health and wellness.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
